Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye. - Wikidata - awgldk - TriplyDB

Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye.

Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye.

http://www.wikidata.org/entity/Q30424219

about

A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery.Efficacy of Antibody Delivery to the Retina and Optic Nerve by Topical Administration Drug, delivery and devices for diabetic retinopathy (3Ds in DR).Recent perspectives on the delivery of biologics to back of the eye.Drug delivery to the eye: what benefits do nanocarriers offer?Retinal Gene Therapy: Surgical Vector Delivery in the Translation to Clinical Trials.Principles of pharmacology in the eye.Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF165 Neutralization.A comparative study of different concentrations of topical bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study.

P2860

Q36342984-86B0A8E7-18FC-4C8C-914B-74F34D8363B4 Q36881990-3C4F2B6A-3743-46DD-8804-A4D9A3543489 Q38832441-59801DFA-73FD-4C5B-A1FF-81DD8D1A78CD Q38940171-D3BBD802-209B-48A9-99D0-036B7B31FF57 Q39130097-A6505996-8CBE-4AD6-B097-31CA57F87FF1 Q39249514-5BB1E743-E855-4D97-800D-687734D537D4 Q45871474-6807B740-0354-47B7-BC07-6FC8A74BB223 Q52609710-87EF2953-3EFD-4CFD-885C-75DD9D91C1D1 Q53516902-4B797334-B382-4B17-A7BE-74FA9A0E5E93

P2860

Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye.

http://www.wikidata.org/entity/Q30424219

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye.

@ast

Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye.

@en

type

label

Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye.

@ast

Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye.

@en

prefLabel

Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye.

@ast

Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye.

@en

P1433

Q30424219-F666A937-9D7B-486A-819E-97926E0E0F41

P1476

Q30424219-DA57CAB5-932F-4180-B351-2BBC71BFC2F6

P2093

Q30424219-0D443BCD-8ED6-48A5-B9FC-3D7FEC7D0F50

Q30424219-107F4519-AC21-4EF1-9225-B6CD2B9EDFF1

Q30424219-748D5BA8-26FD-4155-8154-E77303BA2159

Q30424219-A54E4E0F-0225-4F68-9CBD-BBB651CCBDFA

P2860

Q30424219-0847A9E3-D107-4666-9082-8053A85CCC07

Q30424219-13DC6E3C-F795-4025-A2A1-329238C3F9D5

Q30424219-1A784F56-DB61-404A-91D1-ACFD368EA517

Q30424219-386E1105-370F-4E6C-A119-51508A28C907

Q30424219-39459F09-90E8-47B3-BD6E-0F1D6BA88D36

Q30424219-43197221-D1F0-4C03-B09C-2CAB63B2A4E2

Q30424219-45B7967E-9775-4713-A1B2-B23D1788ACFC

Q30424219-4A0D454A-C7B9-49F7-93C4-F7EB3A8F066A

Q30424219-65906BFF-7CC8-44D1-8B25-AE3D3BBA254C

Q30424219-67AA30F7-1282-4161-9F14-F54BCBDEEE89

P2888

Q30424219-5CFE7252-C39B-48BD-B98C-B7FC749EEAA7

P304

Q30424219-1E848A06-1246-425B-947C-1D14D520F3FF

P31

Q30424219-FAD2EC00-326F-4650-A589-FF920EE11825

P356

Q30424219-B139D2F2-5078-4342-80A2-AF249605C336

P433

Q30424219-6838C4A9-401A-4F6B-84D1-D86ADB1D8578

P478

Q30424219-E6447797-CE33-430A-A29B-8DB6CBAAC854

P577

Q30424219-378B40C6-F4E8-4130-9E8A-B395D87A3DDD

P5875

Q30424219-68661972-D478-4088-A678-EC7E40066ABB

P6179

Q30424219-E7CF6162-8CEE-494E-88E4-4E18C7B242D1

P698

Q30424219-987EE0A5-1D05-48B4-9DA1-C8FA9847DACC

P932

Q30424219-1913ACC1-E5B4-4B46-B8EF-F4DE2B624D99

P356

P1433

P1476

Potential penetration of topical ranibizumab (Lucentis) in the rabbit eye.

@en

P2093

J J Chen

http://www.w3.org/2001/XMLSchema#string

N G Ghazi

http://www.w3.org/2001/XMLSchema#string

S E Ebmeier

http://www.w3.org/2001/XMLSchema#string

W M Sutherland

http://www.w3.org/2001/XMLSchema#string

P2860

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

Ranibizumab for neovascular age-related macular degeneration

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration.

Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond.

Topical and systemic drug delivery to the posterior segments.

Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.

Infectious endophthalmitis after intravitreal injection of antiangiogenic agents.

Drug delivery to the posterior segment of the eye.

P2888

P304

1504-1511

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EYE.2011.225

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51646662

http://www.w3.org/2001/XMLSchema#string

P6179

1046156528

http://www.w3.org/2001/XMLSchema#string

P698

21921952

http://www.w3.org/2001/XMLSchema#string

P932

3213670

http://www.w3.org/2001/XMLSchema#string